Revvity (NYSE:RVTY) Given New $125.00 Price Target at The Goldman Sachs Group

Revvity (NYSE:RVTY - Free Report) had its price objective reduced by The Goldman Sachs Group from $140.00 to $125.00 in a research note released on Tuesday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock.

A number of other equities research analysts have also recently weighed in on the stock. Sanford C. Bernstein cut shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a research report on Friday, January 10th. Raymond James reissued an "outperform" rating and issued a $120.00 target price (down from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. Robert W. Baird cut their price target on Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 29th. JPMorgan Chase & Co. lowered their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 29th. Finally, Barclays decreased their price target on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Revvity presently has a consensus rating of "Moderate Buy" and an average target price of $125.64.

Revvity Trading Up 1.2 %

NYSE RVTY traded up $1.14 during trading on Tuesday, hitting $94.04. The stock had a trading volume of 944,884 shares, compared to its average volume of 931,013. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $11.30 billion, a PE ratio of 42.55, a PEG ratio of 3.82 and a beta of 1.07. The firm has a 50 day moving average price of $102.80 and a 200 day moving average price of $112.07. Revvity has a twelve month low of $88.53 and a twelve month high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, beating analysts' consensus estimates of $0.96 by $0.05. The firm had revenue of $664.76 million during the quarter, compared to analysts' expectations of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The business's quarterly revenue was up 2.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.98 earnings per share. As a group, equities research analysts forecast that Revvity will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.30%. Revvity's payout ratio is currently 11.91%.

Institutional Investors Weigh In On Revvity

Hedge funds and other institutional investors have recently modified their holdings of the stock. Nissay Asset Management Corp Japan ADV increased its holdings in Revvity by 0.6% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 15,023 shares of the company's stock valued at $1,682,000 after acquiring an additional 91 shares in the last quarter. Quarry LP grew its position in shares of Revvity by 45.7% in the fourth quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after purchasing an additional 95 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of Revvity by 2.4% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,214 shares of the company's stock worth $470,000 after purchasing an additional 100 shares in the last quarter. HB Wealth Management LLC raised its position in shares of Revvity by 4.6% during the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company's stock worth $266,000 after purchasing an additional 104 shares during the last quarter. Finally, Signaturefd LLC raised its position in shares of Revvity by 6.8% during the 4th quarter. Signaturefd LLC now owns 1,668 shares of the company's stock worth $186,000 after purchasing an additional 106 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.